US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL, SHANGHAI SHENGDI PHARMACEUTICAL on Sept. 1 for "Human interleukin-2 variant or derivative thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,067, issued on Sept. 1, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China), SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai) and SHANGHAI SHENGDI PHARMACEUTICAL Co. LTD. (Shanghai).

"Human interleukin-2 variant or derivative thereof" was invented by Lei Chen (Lianyungang, China), Qiyue Hu (Shanghai), Hu Ge (Shanghai), Yuan Lin (Shanghai), Hongwei Wang (Lianyungang, China), Yangchao Ou (Lianyungang, China), Xianglin Kong (Lianyungang, China), Cheng Liao (Shanghai) and Lianshan Zhang (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a human interleukin-2 (IL-2) variant having one or more amino acid m...